Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Renshen Guben is a Traditional Chinese Medicine (TCM) formulation, typically administered as an oral liquid or pill, designed to replenish vital energy (Qi) and nourish the body's essence. Developed and studied by institutions such as Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, it is primarily indicated for the treatment of fatigue and weakness. The formulation typically contains *Panax ginseng* and other herbal components aimed at "consolidating the foundation" (Guben) in TCM theory. It is currently being evaluated in clinical trials for its efficacy in managing post-COVID-19 fatigue syndrome, where it is thought to modulate immune response and improve physical recovery through its multi-herbal constituents.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Renshen Guben.